IGHE and egg allergy: In LEAP participants who had egg allergy with mild or no eczema at enrollment, the proportion developing peanut allergy, with IgE levels to peanut of 0.1 kU/L or greater at baseline, was 89% (8/9) overall and 88% (7/8) in the avoidance group (the P value for this subgroup analysis within the mild eczema group [n = 105] was significant: P = .0002).